Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cigna Corp
(NY:
CI
)
294.40
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cigna Corp
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
UnitedHealth, CVS, Molina Get 2026 Boost From ACA Premiums Rise — Mark Cuban Slams Insurers As ‘Too Big To Care’
↗
January 07, 2026
With enhanced ACA subsidies now expired, average out-of-pocket premiums for Obamacare users are expected to more than double.
Via
Stocktwits
Are CVS, UnitedHealth, Cigna Hiding Billions In PBM Rebates? New Report Claims They Are
↗
January 06, 2026
A new report investigates how the three biggest health care giants in the U.S.are allegedly using shell companies to hide billions of dollars.
Via
Benzinga
Earnings Preview: What to Expect From Cigna's Report
January 05, 2026
Cigna will release its fourth-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.
Via
Barchart.com
1 Healthcare Stock on Our Watchlist and 2 We Ignore
January 04, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also...
Via
StockStory
Topics
Stocks
BofA Unveils Q1 2026 Top Stock Picks: High-Conviction Bets on AI Infrastructure and Health Care Valuations
January 02, 2026
As the opening bells of 2026 ring across Wall Street, Bank of America Securities has released its highly anticipated "Top 10 U.S. Stock Ideas for Q1 2026." The report, a cornerstone for institutional...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
January 02, 2026
As the calendar turns to 2026, the landscape for weight-loss and diabetes medication has been fundamentally transformed. What began two years ago as a "wild west" of $1,000-a-month list prices and...
Via
MarketMinute
Topics
Economy
Intellectual Property
What Does the Market Think About The Cigna Group?
↗
January 01, 2026
Via
Benzinga
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?
December 31, 2025
Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, well below the S&P 500’s 11.2% gain. This may have investors wondering how...
Via
StockStory
Topics
Stocks
Supply Chain
The Great Unbundling: How Federal Scrutiny is Dismantling the PBM Profit Machine
December 31, 2025
The long-standing dominance of Pharmacy Benefit Managers (PBMs) in the American healthcare system has reached a critical inflection point as 2025 draws to a close. For decades, these "middlemen"...
Via
MarketMinute
Cigna Group (CI) Secures ‘Buy’ Upgrades as Analysts Dismiss PBM Regulatory Fears as Market Overreaction
December 31, 2025
As the curtain closes on 2025, the investment community is witnessing a significant shift in sentiment regarding the managed care sector. Cigna Group (NYSE: CI) has become the centerpiece of this...
Via
MarketMinute
Topics
Government
Lawsuit
Dolce MD Offers Comprehensive Concierge Primary Care Services in Laguna Beach, CA
December 31, 2025
Via
GetFeatured
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years
↗
December 29, 2025
Via
Benzinga
2 Reasons to Like CI (and 1 Not So Much)
December 18, 2025
Over the last six months, Cigna’s shares have sunk to $276.25, producing a disappointing 12.1% loss - a stark contrast to the S&P 500’s 13% gain. This may have investors wondering how to approach the...
Via
StockStory
Topics
Stocks
Supply Chain
Chubb Limited (CB) Deep Dive: The Global Risk Machine in 2025
December 18, 2025
As of December 18, 2025, Chubb Limited (NYSE: CB) stands as the preeminent titan of the global property and casualty (P&C) insurance landscape. With a market capitalization surging toward $120 billion...
Via
PredictStreet
Topics
Artificial Intelligence
Climate Change
Economy
Cigna Offers Cleaner Growth Than Other Health Insurers, Says Analyst
↗
December 17, 2025
BofA outlines risks and upside for managed care stocks, favoring Cigna and Alignment while flagging Medicare and Medicaid uncertainty.
Via
Benzinga
Humana, Molina Jump As House GOP Revolt Reignites Fight To Extend Obamacare Subsidies — Retail Warns ‘Healthcare Wreck’
↗
December 17, 2025
Health insurance stocks split after a House GOP revolt revived debate over ACA subsidies, while a year-end extension was ruled out.
Via
Stocktwits
Molina Healthcare (MOH): Buy, Sell, or Hold Post Q3 Earnings?
December 15, 2025
What a brutal six months it’s been for Molina Healthcare. The stock has dropped 42.1% and now trades at $168.08, rattling many shareholders. This was partly due to its softer quarterly results and...
Via
StockStory
Topics
Supply Chain
Bristol Myers Squibb (BMS): Navigating the Patent Cliff with a Renewed Pipeline and Strategic Acquisitions
December 15, 2025
Date: December 15, 2025 1. Introduction Bristol Myers Squibb (BMS) (NYSE: BMY) is a global biopharmaceutical powerhouse focused on discovering, developing, manufacturing, and distributing innovative...
Via
PredictStreet
Topics
Intellectual Property
Lawsuit
Supply Chain
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
December 10, 2025
From
Schall Law
Via
GlobeNewswire
Meet the 2.5% Yield Dividend Stock That Could Soar in 2026
↗
December 09, 2025
UnitedHealth Group raised its dividend in each of the last 16 years.
Via
The Motley Fool
The JOLTS Report: A Cooling Labor Market Ignites Rate Cut Hopes Amidst Economic Uncertainty
December 09, 2025
The latest Job Openings and Labor Turnover Survey (JOLTS) data, released on December 9, 2025, for the month of October, presents a nuanced picture of the U.S. labor market. While a slight uptick in job...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Workforce
HIAAH Partners with Alary Health Spa to Deliver Holistic Wellness: Integrating Mental Health with Rejuvenation and Total Body Vitality
December 08, 2025
Via
Press Release Distribution Service
From Ivy League to Italian Vines: New Novel Captures the Ultimate Life Transformation
December 03, 2025
Via
AB Newswire
Topics
Bonds
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
December 03, 2025
From
Schall Law
Via
GlobeNewswire
A Look Into Cigna Group Inc's Price Over Earnings
↗
December 02, 2025
Via
Benzinga
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
December 02, 2025
From
The Schall Law Firm
Via
Business Wire
If You Invested $100 In Cigna Group Stock 20 Years Ago, You Would Have This Much Today
↗
December 02, 2025
Via
Benzinga
Is Cigna Stock Underperforming the Nasdaq?
November 28, 2025
Even though Cigna has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.
Via
Barchart.com
Topics
Stocks
Is Elevance Health Stock Outperforming the Nasdaq?
November 26, 2025
Elevance Health has outpaced the Nasdaq Composite in recent months, and analysts remain optimistic about the stock’s prospects.
Via
Barchart.com
Topics
Stocks
3 Large-Cap Stocks to Consider Right Now
November 25, 2025
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.